Testing NAIC for advanced mouth and throat cancer
Part of Cancer clinical trials.
This study looks at how well NAIC treatment helps shrink advanced mouth or throat cancer. It aims to find patterns in how tumors respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with advanced mouth or throat cancer (squamous cell carcinoma).
- You are between 18 and 80 years old.
- You have not had other cancers or treatments for them.
- Your blood, liver, and kidney function are adequate based on recent lab tests.
- You are healthy enough to tolerate NAIC and surgery.
- You do not have cancer that has spread to other parts of the body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding an immunotherapy drug (sintilimab) to standard chemotherapy before and after surgery can improve outcomes for people with advanced oral squamous cell carcinoma. The treatment is given first to shrink the tumor, then again after surgery to help prevent recurrence.
This trial tests a combination of an immunotherapy drug (adebrelimab) and two standard chemotherapy drugs (carboplatin and albumin-bound paclitaxel) before surgery for advanced oral cancer that can be removed. The goal is to see if this approach helps shrink the tumor and improve outcomes.
This trial tests a combination of drugs (tislelizumab, cetuximab, and chemotherapy) before and after surgery for people whose mouth or throat cancer has returned after previous treatment. The goal is to see if this approach can help shrink or control the cancer and improve outcomes.
This trial is testing a combination of low-dose radiation, immunotherapy, and chemotherapy for people with advanced oral cancer that hasn't been treated before. The goal is to see if this approach can help control the cancer and possibly improve outcomes.
This study compares different ways to treat the neck in patients with early-stage oral cancer that hasn't spread to the neck. The goal is to find which approach works best while keeping side effects low.
This study is testing whether a combination of chemotherapy and immunotherapy before surgery can help treat advanced oral cancer. Researchers will also look at how the cancer changes the bacteria in your mouth.
Hear when a new Oropharyngeal Squamous Cell Carcinoma (SCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.